Cargando...

Preclinical Efficacy of a Trivalent Human FcγRI-Targeted Adjuvant-Free Subunit Mucosal Vaccine against Pulmonary Pneumococcal Infection

Lack of safe and effective mucosal adjuvants has severely hampered the development of mucosal subunit vaccines. In this regard, we have previously shown that immunogenicity of vaccine antigens can be improved by targeting the antigens to the antigen-presenting cells. Specifically, groups of mice imm...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Vaccines (Basel)
Main Authors: Kumar, Sudeep, Sunagar, Raju, Gosselin, Edmund J.
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2020
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7349865/
https://ncbi.nlm.nih.gov/pubmed/32340134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8020193
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!